btlines

GX1 NewConnect Periodic report · PAP Biznes

Genxone SA (GX1) · Q2 2026 results

Share price: 4.57 zł · 2026-11-10

Results Q2 2026 vs Q2 2025 · year over year · published 12 Aug 2026 and 12 Aug 2025

Net loss narrowed year on year. The report's language is unchanged.

Only a basic analysis is available for this company at the moment.

1 · Numbers

Loss narrowed

Net income vs Q2 2025

Net income -845.6K vs -1.3M

2 · How the report reads

Unchanged

Language tone vs last period

Report language: typical for a company report — about as upbeat as in Q2 2025.

Weak signal: formal report language, not a call.

3 · What stood out Nothing unusual flagged this period.

Read between the lines

No major shifts flagged this period.

Tone

How upbeat the language was, compared with other companiesiTone counts positive minus negative finance words, adjusted for length. Executives mostly speak positively, so the labels compare each call with every company's latest call: “typical” is the middle third, “very upbeat” the top tenth, “cautious” the bottom tenth.. Dot: Q2 2026. Ring: Q2 2025.

Report language Typical (was typical)

Typical for a company report — about as upbeat as in Q2 2025. Periodic reports carry legally required risk wording, so their tone moves little and is a weak signal.

Full figures

PLN · PAP Biznes report (2026-08-12)

Metric Q2 2026 Q2 2025 Change
Revenue 567.0K —
Net income -845.6K -1.3M Loss narrowed
P/E 12-mo loss 12-mo loss —

Topics

Topics are drawn from the full report text, not management commentary.

Most discussed now

  • In view of the above, the Issuer currently does not identify the potential consequences of Russia's armed aggression against Ukraine as a…
  • The Company's primary business profile includes the acquisition of shares and stakes in other entities with the intent of selling them or…

Faded since Q2 2025

  • Nothing dropped away.

Latest announcements

Official filings, newest first.

Similar companies

Healthcare · Biotechnology
All Healthcare companies →